{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:43Z","timestamp":1761578623428},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008744","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:26Z","timestamp":1511378006000},"page":"e8744","source":"Crossref","is-referenced-by-count":7,"title":["Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation"],"prefix":"10.1097","volume":"96","author":[{"given":"Xiang","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanbiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-58-20210309","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma.","volume":"511","year":"2014","journal-title":"Nature"},{"key":"R2-58-20210309","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"R3-58-20210309","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1200\/JCO.2012.43.9422","article-title":"MET as a possible target for non-small-cell lung cancer","volume":"31","author":"Sadiq","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-58-20210309","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ctrv.2013.02.001","article-title":"The emerging role of MET\/HGF inhibitors in oncology","volume":"39","author":"Scagliotti","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R5-58-20210309","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1158\/1078-0432.CCR-09-0070","article-title":"Ethnic differences and functional analysis of MET mutations in lung cancer","volume":"15","author":"Krishnaswamy","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R6-58-20210309","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/0008-5472.CAN-05-2749","article-title":"Somatic mutations lead to an oncogenic deletion of met in lung cancer","volume":"66","author":"Kong-Beltran","year":"2006","journal-title":"Cancer Res"},{"key":"R7-58-20210309","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1535-6108(03)00136-3","article-title":"Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases","volume":"3","author":"Peschard","year":"2003","journal-title":"Cancer Cell"},{"key":"R8-58-20210309","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","article-title":"Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors","volume":"5","author":"Frampton","year":"2015","journal-title":"Cancer Discov"},{"key":"R9-58-20210309","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/JTO.0000000000000478","article-title":"MET mutation associated with responsiveness to crizotinib","volume":"10","author":"Waqar","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R10-58-20210309","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.cllc.2015.01.009","article-title":"Response to crizotinib in a patient with lung adenocarcinoma harboring a MET splice site mutation","volume":"16","author":"Jenkins","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"R11-58-20210309","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/2159-8290.CD-14-1467","article-title":"Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping","volume":"5","author":"Paik","year":"2015","journal-title":"Cancer Discov"},{"key":"R12-58-20210309","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2015.10.028","article-title":"Responses to the multitargeted MET\/ALK\/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation","volume":"90","author":"Jorge","year":"2015","journal-title":"Lung Cancer"},{"key":"R13-58-20210309","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jtho.2016.01.017","article-title":"Lazarus-type response to crizotinib in a patient with poor performance status and advanced MET exon 14 skipping mutation-positive lung adenocarcinoma","volume":"11","author":"Shea","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R14-58-20210309","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10637-016-0332-0","article-title":"A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib","volume":"34","author":"Mahjoubi","year":"2016","journal-title":"Invest New Drugs"},{"key":"R15-58-20210309","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"R16-58-20210309","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000337106","article-title":"Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells","volume":"79","author":"Ksiazkiewicz","year":"2012","journal-title":"Pathobiology"},{"key":"R17-58-20210309","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ajpath.2010.12.003","article-title":"Circulating tumor cells as a window on metastasis biology in lung cancer","volume":"178","author":"Hou","year":"2011","journal-title":"Am J Pathol"},{"key":"R18-58-20210309","doi-asserted-by":"crossref","first-page":"e0123976","DOI":"10.1371\/journal.pone.0123976","article-title":"Classification of circulating tumor cells by epithelial-mesenchymal transition markers","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"R19-58-20210309","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"R20-58-20210309","first-page":"6272","article-title":"c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions","volume":"63","author":"Ma","year":"2003","journal-title":"Cancer Res"},{"key":"R21-58-20210309","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways.","volume":"455","year":"2008","journal-title":"Nature"},{"key":"R22-58-20210309","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"R23-58-20210309","first-page":"bcr","article-title":"Long-lasting response to crizotinib in brain metastases due to EML4-ALK-rearranged non-small-cell lung cancer.","volume":"pii","author":"Kinoshita","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R24-58-20210309","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2010.34.1313","article-title":"CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib","volume":"29","author":"Costa","year":"2011","journal-title":"J Clin Oncol"},{"key":"R25-58-20210309","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov"},{"key":"R26-58-20210309","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-017-9211-0_6","article-title":"p53 mutation in the genesis of metastasis","volume":"85","author":"Yeudall","year":"2014","journal-title":"Subcell Biochem"},{"key":"R27-58-20210309","doi-asserted-by":"crossref","first-page":"e57523","DOI":"10.1371\/journal.pone.0057523","article-title":"Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas","volume":"8","author":"Kreahling","year":"2013","journal-title":"PLoS One"},{"key":"R28-58-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4161\/cbt.9.7.11115","article-title":"MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil","volume":"9","author":"Hirai","year":"2010","journal-title":"Cancer Biol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:39Z","timestamp":1620960159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711270-00058"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":28,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008744","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}